𝔖 Bobbio Scriptorium

✦ LIBER ✦

159 Blocking VEGF and EGF receptor signaling with ZD6474 sensitizes human non-small cell lung cancer to chemotherapy with paclitaxel

✍ Scribed by W. Wu; T. Shintani; M.S. O'Reilly; R.S. Herbst

Book ID: 118621342
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 289 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)80167-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antitumor activity of the epidermal grow

Antitumor activity of the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) ZD1839 (‘lressa’), alone or combined with gemcitabine and vinorelbine platinum-based chemotherapy, in human non-small-cell lung cancer (NSCLC) xenografts

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Phase II Trial of Mapatumumab, a Fully H

Phase II Trial of Mapatumumab, a Fully Human Agonist Monoclonal Antibody to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 1 (TRAIL-R1), in Combination With Paclitaxel and Carboplatin in Patients With Advanced Non–Small-Cell Lung Cancer

✍ von Pawel, Joachim; Harvey, Jimmie H.; Spigel, David R.; Dediu, Mircea; Reck, Ma 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 569 KB